| Cardiovascular / Cardiology News From Medical News Today |
| Stanford Scientists Make Stem Cells Pluripotent Using Virus-Free Technique Tiny circles of DNA are the key to a new and easier way to transform stem cells from human fat into induced pluripotent stem cells for use in regenerative medicine, say scientists at the Stanford University School of Medicine... |
| Simple, Quick Test Can Send Patient Safely Home From ER After Chest Pain Researchers at the Methodist DeBakey Heart & Vascular Center have shown that a simple, inexpensive test can determine whether it is safe to send home a patient who comes to the emergency room with chest pain. \"It is imperative to accurately diagnose patients who come to the emergency department with chest pain,\" said Dr... |
| Gene Variant For Biological Ageing In Humans Discovered Scientists from the UK and The Netherlands have identified for the first time a variant of a gene that is linked to biological ageing in humans and suggest the discovery will help us better understand cancer and diseases of ageing... |
| HealthSpring Home Visit Nurse Intercepts Cardiac Arrest Olive Branch, Miss. resident Glenn Lusk has a special perspective on the value of his Medicare Advantage plan. It was a HealthSpring-contracted nurse practitioner who discovered during a home visit in November that Lusk was experiencing serious heart trouble. \"Somebody up above was looking out for me,\" Lusk said... |
| Sorin Group Announces Market Release And First Implant Of Next-Generation Cardiac Resynchronization Therapy Defibrillator Sorin Group (MIL:SRN) (Reuters Code: SORN.MI), a global leader in the treatment of cardiovascular disease, announced U.S. FDA approval and first implant of its next-generation of cardiac resynchronization therapy defibrillator (CRT-D), Paradym? CRT Model 8750... |
| Bioheart Launches First US FDA Approved Clinical Trial That Tests Gene-Modified Stem Cell Therapy In Patients With Congestive Heart Failure Bioheart, Inc., (OTCBB:BHRT) announced that the company has commenced work on its REGEN trial, a Phase I Clinical Trial to test genetically modified MyoCell® in patients suffering from Congestive Heart Failure (CHF). Bioheart's MyoCell® is a regenerative cell therapy that uses myoblasts, or muscle stem cells,that are grown from a patient's own muscle... |
| St. Jude Medical Announces European Approval Of Smaller, Higher Power ICD And CRT-D Devices With New Heart Failure Monitors St. Jude Medical, Inc. (NYSE:STJ) announced European CE Mark approval and first implants of its Fortify(TM) and Fortify ST implantable cardioverter defibrillators (ICD) and Unify(TM) cardiac resynchronization therapy defibrillator (CRT-D). The devices will be fully launched in Europe later this spring, and U.S... |
| New Blood Test For Coronary Artery Disease Now Available At Vanderbilt Heart And Vascular Institute Just in time for American Heart Month, Vanderbilt Heart and Vascular Institute is offering a new blood test that can predict if a patient is at high risk for heart disease. Vanderbilt is among the first institutions in the country, and the only one in Tennessee, to offer this test... |
| Cord Blood-Derived CD133+ Cells Improve Cardiac Function After Myocardial Infarction Researchers at the PontifĂcia Universidade Catolica do Parana and Instituto Carlos Chagas have evaluated the therapeutic potential of purified and expanded CD133+ cells human umbilical cord blood (HUCB)-derived in treating myocardial infarction by intramyocardially injecting them into a rat model... |
| Three Year Partnership Between Go Red For Women And Dona Bertarelli's Ladycat Enables Campaign To Grow By 56% The three year partnership between Dona Bertarelli, her Decision 35 catamaran Ladycat (SUI10) and Go Red for Women, the international campaign of the World Heart Federation to raise public awareness of heart disease and stroke in women, ended successfully in December 2009... |
| RSS integration by RSSinclude |